Telmisartan + ChlorthalidoneThird Party Manufacturing in India

Telmisartan + Chlorthalidone works by pairing a long-acting angiotensin II receptor blocker with a potent thiazide-like diuretic. Telmisartan blocks AT1 receptors to inhibit vasoconstriction, while Chlorthalidone acts on the distal convoluted renal tubule to inhibit sodium and chloride reabsorption. It acts on these dual pathways to help the body diminish intravascular volume and decrease systemic vascular resistance. Unlike short-acting diuretics, Chlorthalidone provides a prolonged, smooth antihypertensive profile over 24 hours. It is highly effective and well-tolerated.

Therapeutic Uses

• Refractory Hypertension: Designed for patients requiring multi-mechanism intervention to reach targeted blood pressure guidelines.
• Volume-Dependent Hypertension: Provides optimal management for patients whose hypertension is compounded by fluid retention.
• Stroke Prevention: Lowers long-term arterial shear stress to prevent acute cerebrovascular events.

Why Manufacturers Choose Telmisartan + Chlorthalidone

Securing Telmisartan + Chlorthalidone third party manufacturing in India is a highly strategic choice for expanding chronic-care pharmaceutical catalogs. Managing the dual compression of a highly hygroscopic active with a low-dose diuretic demands precise ingredient granulation and specialized blending validation. Our partner facilities leverage automated, climate-regulated equipment that satisfies WHO-GMP standards, delivering exceptional content uniformity across every production run.